HITS-CLIP reveals key regulators of nuclear receptor signaling in breast cancer

Breast Cancer Research and Treatment

Volumn 146, Issue 1, 2014, Pages 85-97

  Pillai, Manoj M ^a   Gillen, Austin E ^b   Yamamoto, Tomomi M ^b   Kline, Enos ^b   Brown, Joseph ^b   Flory, Kale ^b   Hesselberth, Jay R ^b   Kabos, Peter ^b  

^a YALE CANCER CENTER   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Estrogen; HITS CLIP; MicroRNA; Nuclear receptor

Indexed keywords

ANDROGEN RECEPTOR; CELL NUCLEUS RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; MICRORNA; MICRORNA 141; MICRORNA 193A; MICRORNA 193B 3P; MICRORNA 200C; MICRORNA 221; MICRORNA 222; MICRORNA 26; MICRORNA 9 5P; RETINOIC ACID RECEPTOR; STEROID RECEPTOR COACTIVATOR 3; UNCLASSIFIED DRUG; CELL RECEPTOR; ESTROGEN; MESSENGER RNA; MIRN92 MICRORNA, HUMAN; STEROID RECEPTOR;

3' UNTRANSLATED REGION; ARTICLE; BREAST CANCER; CANCER PROGNOSIS; CANCER RECURRENCE; CELL DIFFERENTIATION; CONTROLLED STUDY; CROSS LINKING; EPIDERMAL GROWTH FACTOR RECEPTOR 2 POSITIVE BREAST CANCER; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; RECEPTOR DOWN REGULATION; RNA ANALYSIS; RNA SEQUENCE; TRIPLE NEGATIVE BREAST CANCER; BREAST NEOPLASMS; CANCER GRADING; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; METABOLISM; MORTALITY; PROGNOSIS; RNA INTERFERENCE; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; ESTROGENS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOPRECIPITATION; MICRORNAS; NEOPLASM GRADING; PROGNOSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, ESTROGEN; RECEPTORS, STEROID; RNA INTERFERENCE; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84903703801     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-3004-9     Document Type: Article

References (48)

1. Desantis C, Ma J, Bryan L, Jemal A (2013) Breast cancer statistics, 2013. CA Cancer J Clin. doi:10.3322/caac.21203
2. Musgrove EA, Sutherland RL (2009) Biological determinants of endocrine resistance in breast cancer. Nat Rev Cancer 9:631-643. doi:10.1038/nrc2713
3. Croce CM (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714. doi:10.1038/nrg2634
4. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531. doi:10.1038/nrg1379 (Pubitemid 38868508)
5. Li H, Bian C, Liao L, Li J, Zhao RC (2010) miR-17-5p promotes human breast cancer cell migration and invasion through suppression of HBP1. Breast Cancer Res Treat. doi:10.1007/s10549-010-0954-4
6. Zhao J-J, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ (2008) MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079-31086. doi:10.1074/jbc.M806041200
7. Thomson DW, Bracken CP, Goodall GJ (2011) Experimental strategies for microRNA target identification. Nucleic Acids Res 39:6845-6853. doi:10.1093/nar/gkr330
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297
9. Rajewsky N (2006) microRNA target predictions in animals. Nat Genet 38(Suppl):S8-S13. doi:10.1038/ng1798
10. Chi SW, Zang JB, Mele A, Darnell RB (2009) Argonaute HITSCLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486. doi:10.1038/nature08170
11. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, Clark TA, Schweitzer AC, Blume JE, Wang X, Darnell JC, Darnell RB (2008) HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456:464-469. doi:10.1038/nature07488 (Pubitemid 352759008)
12. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, Radu M, Chaitcik S, Brenner HJ (1979) Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15:659-670 (Pubitemid 9198534)
13. Korch C, Spillman MA, Jackson TA, Jacobsen BM, Murphy SK, Lessey BA, Jordan VC, Bradford AP (2012) DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination. Gynecol Oncol 127:241-248. doi:10.1016/j.ygyno.2012.06.017
14. Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B (2010) MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS One 5:e14304. doi:10.1371/journal.pone.0014304
15. Chen C-Z, Li L, Lodish HF, Bartel DP (2004) MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86. doi:10.1126/science. 1091903 (Pubitemid 38055775)
16. Balakrishnan I, Yang X, Brown J, Ramakrishnan A, Torok-Storb B, Kabos P, Hesselberth JR, Pillai MM (2013) Genome-wide analysis of miRNA-mRNA interactions in marrow stromal cells. Stem Cells. doi:10.1002/stem.1531
17. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H (2002) Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21:2000-2008. doi:10.1038/sj.onc.1205260 (Pubitemid 34270888)
18. Yeo GW, Coufal NG, Liang TY, Peng GE, Fu X-D, Gage FH (2009) An RNA code for the FOX2 splicing regulator revealed by mapping RNA - protein interactions in stem cells. Nat Struct Mol Biol 16:130-137. doi:10.1038/nsmb.1545
19. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J (2011) microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res 71:5635-5645. doi:10.1158/0008-5472.CAN-11-0489
20. Cancer Genome Atlas Network (2012) Comprehensive molecular portraits of human breast tumours. Nature 490:61-70. doi:10.1038/nature11412
21. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe J-P, Tong F, Speed T, Spellman PT, DeVries S, Lapuk A, Wang NJ, Kuo W-L, Stilwell JL, Pinkel D, Albertson DG, Waldman FM, McCormick F, Dickson RB, Johnson MD, Lippman M, Ethier S, Gazdar A, Gray JW (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10:515-527. doi:10.1016/j.ccr.2006.10.008 (Pubitemid 44854747)
22. Darnell RB (2010) HITS-CLIP: panoramic views of protein - RNA regulation in living cells. Wiley Interdiscip Rev RNA 1:266-286. doi:10.1002/wrna.31
23. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57-63. doi:10.1038/nrg2484
24. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ (2007) Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 67:7972-7976. doi:10.1158/0008-5472.CAN-07-1058 (Pubitemid 47395127)
25. Stinson S, Lackner MR, Adai AT, Yu N, Kim H-J, O'Brien C, Spoerke J, Jhunjhunwala S, Boyd Z, Januario T, Newman RJ, Yue P, Bourgon R, Modrusan Z, Stern HM, Warming S, de Sauvage FJ, Amler L, Yeh R-F, Dornan D (2011) TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer. Sci Signal 4:ra41. doi:10.1126/scisignal.2001538
26. Lopes CT, Franz M, Kazi F, Donaldson SL, Morris Q, Bader GD (2010) Cytoscape web: an interactive web-based network browser. Bioinforma Oxf Engl 26:2347-2348. doi:10.1093/bioinformatics/btq430
27. Avery-Kiejda KA, Braye SG, Forbes JF, Scott RJ (2014) The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer. BMC Cancer 14:253. doi:10.1186/1471-2407-14-253
28. Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y, Nephew KP, Croce CM (2010) MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 102:706-721. doi:10.1093/jnci/djq102
29. Castellano L, Giamas G, Jacob J, Coombes RC, Lucchesi W, Thiruchelvam P, Barton G, Jiao LR, Wait R, Waxman J, Hannon GJ, Stebbing J (2009) The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response. Proc Natl Acad Sci 106:15732-15737. doi:10.1073/pnas.0906947106
30. Chen L, Zheng J, Zhang Y, Yang L, Wang J, Ni J, Cui D, Yu C, Cai Z (2011) Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclindependent and -independent pathways. Mol Ther J Am Soc Gene Ther 19:1521-1528. doi:10.1038/mt.2011.64
31. Keaveney M, Parker MG, Gannon F (1993) Identification of a functional role for the 3' region of the human oestrogen receptor gene. J Mol Endocrinol 10:143-152 (Pubitemid 23100296)
32. Miranda KC, Huynh T, Tay Y, Ang Y-S, Tam W-L, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126:1203-1217. doi:10.1016/j.cell.2006.07.031 (Pubitemid 44380294)
33. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10:1507-1517. doi:10.1261/rna.5248604 (Pubitemid 39288185)
34. Buache E, Etique N, Alpy F, Stoll I, Muckensturm M, Reina-San-Martin B, Chenard MP, Tomasetto C, Rio MC (2011) Deficiency in trefoil factor 1 (TFF1) increases tumorigenicity of human breast cancer cells and mammary tumor development in TFF1-knockout mice. Oncogene 30:3261-3273. doi:10.1038/onc.2011. 41
35. Foekens JA, Rio MC, Seguin P, van Putten WL, Fauque J, Nap M, Klijn JG, Chambon P (1990) Prediction of relapse and survival in breast cancer patients by pS2 protein status. Cancer Res 50:3832-3837 (Pubitemid 20225591)
36. Clark GM, McGuire WL, Hubay CA, Pearson OH, Marshall JS (1983) Progesterone receptors as a prognostic factor in stage II breast cancer. N Engl J Med 309:1343-1347 (Pubitemid 14246555)
37. Jordan VC, O'Malley BW (2007) Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 25:5815-5824. doi:10.1200/JCO.2007.11.3886
38. Osborne CK, Bardou V, Hopp TA, Chamness GC, Hilsenbeck SG, Fuqua SAW, Wong J, Allred DC, Clark GM, Schiff R (2003) Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J Natl Cancer Inst 95:353-361 (Pubitemid 36395255)
39. Arpino G, Wiechmann L, Osborne CK, Schiff R (2008) Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance. Endocr Rev 29:217-233. doi:10.1210/er.2006-0045 (Pubitemid 351519691)
40. Osborne CK, Schiff R (2011) Mechanisms of endocrine resistance in breast cancer. Annu Rev Med 62:233-247. doi:10.1146/annurev-med-070909-182917
41. Papai G, Weil PA, Schultz P (2011) New insights into the function of transcription factor TFIID from recent structural studies. Curr Opin Genet Dev 21:219-224. doi:10.1016/j.gde.2011.01.009
42. Gasparini P, Fassan M, Cascione L, Guler G, Balci S, Irkkan C, Paisie C, Lovat F, Morrison C, Zhang J, Scarpa A, Croce CM, Shapiro CL, Huebner K (2014) Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic options. PLoS One 9:e88525. doi:10.1371/journal.pone.0088525
43. Park S, Park HS, Koo JS, Yang WI, Kim SI, Park B-W (2012) Higher expression of androgen receptor is a significant predictor for better endocrine-responsiveness in estrogen receptor-positive breast cancers. Breast Cancer Res Treat 133:311-320. doi:10.1007/s10549-011-1950-z
44. Peters KM, Edwards SL, Nair SS, French JD, Bailey PJ, Salkield K, Stein S, Wagner S, Francis GD, Clark SJ, Brown MA (2012) Androgen receptor expression predicts breast cancer survival: the role of genetic and epigenetic events. BMC Cancer 12:132.doi:10.1186/1471-2407-12-132
45. Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, Fluge O, Pergamenschikov A, Williams C, Zhu SX, Lønning PE, Børre-sen-Dale AL, Brown PO, Botstein D (2000) Molecular portraits of human breast tumours. Nature 406:747-752. doi:10.1038/35021093
46. Helwak A, Kudla G, Dudnakova T, Tollervey D (2013) Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 153:654-665. doi:10.1016/j.cell.2013.03.043
47. Kivioja T, Vaharautio A, Karlsson K, Bonke M, Enge M, Linnarsson S, Taipale J (2012) Counting absolute numbers of molecules using unique molecular identifiers. Nat Methods 9:72-74. doi:10.1038/nmeth.1778
48. Kishore S, Jaskiewicz L, Burger L, Hausser J, Khorshid M, Zavolan M (2011) A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat Methods 8:559-564. doi:10.1038/nmeth.1608